Cdk Associates, L.l.c. - Net Worth and Insider Trading

Cdk Associates, L.l.c. Net Worth

The estimated net worth of Cdk Associates, L.l.c. is at least $16 Million dollars as of 2024-12-26. Cdk Associates, L.l.c. is the 10% Owner of Strongbridge Biopharma PLC and owns about 8,060,682 shares of Strongbridge Biopharma PLC (SBBP) stock worth over $16 Million. Cdk Associates, L.l.c. is the 10% Owner of Kala Bio Inc and owns about 4,300 shares of Kala Bio Inc (KALA) stock worth over $29,885. Cdk Associates, L.l.c. is also the Director of Molecular Templates Inc and owns about 105,616 shares of Molecular Templates Inc (MTEM) stock worth over $5,862. Details can be seen in Cdk Associates, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cdk Associates, L.l.c. has not made any transactions after 2020-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Cdk Associates, L.l.c.

To

Cdk Associates, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cdk Associates, L.l.c. owns 4 companies in total, including Strongbridge Biopharma PLC (SBBP) , Molecular Templates Inc (MTEM) , and Kala Bio Inc (KALA) among others .

Click here to see the complete history of Cdk Associates, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Cdk Associates, L.l.c.

Ticker Comapny Transaction Date Type of Owner
SBBP Strongbridge Biopharma PLC 2020-09-18 10 percent owner
MTEM Molecular Templates Inc 2018-12-26 director
KALA Kala Bio Inc 2017-07-20 10 percent owner
LIMIT LIMIT 2016-07-12 other: See Remarks Section

Cdk Associates, L.l.c. Latest Holdings Summary

Cdk Associates, L.l.c. currently owns a total of 3 stocks. Among these stocks, Cdk Associates, L.l.c. owns 8,060,682 shares of Strongbridge Biopharma PLC (SBBP) as of September 18, 2020, with a value of $16 Million and a weighting of 99.78%. Cdk Associates, L.l.c. owns 4,300 shares of Kala Bio Inc (KALA) as of July 20, 2017, with a value of $29,885 and a weighting of 0.18%. Cdk Associates, L.l.c. also owns 105,616 shares of Molecular Templates Inc (MTEM) as of December 26, 2018, with a value of $5,862 and a weighting of 0.04%.

Latest Holdings of Cdk Associates, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SBBP Strongbridge Biopharma PLC 2020-09-18 8,060,682 2.00 16,121,364
KALA Kala Bio Inc 2017-07-20 4,300 6.95 29,885
MTEM Molecular Templates Inc 2018-12-26 105,616 0.06 5,862

Holding Weightings of Cdk Associates, L.l.c.


Cdk Associates, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 1 transactions in Strongbridge Biopharma PLC (SBBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Strongbridge Biopharma PLC is the acquisition of 1,479,377 shares on September 18, 2020, which cost Cdk Associates, L.l.c. around $3 Million.

According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 0 transactions in Kala Bio Inc (KALA) over the past 5 years. The most-recent trade in Kala Bio Inc is the acquisition of 4,300 shares on July 20, 2017, which cost Cdk Associates, L.l.c. around $3 Million.

According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 0 transactions in Molecular Templates Inc (MTEM) over the past 5 years. The most-recent trade in Molecular Templates Inc is the acquisition of 1,667 shares on December 26, 2018, which cost Cdk Associates, L.l.c. around $86,250.

Insider Trading History of Cdk Associates, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cdk Associates, L.l.c. Trading Performance

GuruFocus tracks the stock performance after each of Cdk Associates, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cdk Associates, L.l.c. is 6.12%. GuruFocus also compares Cdk Associates, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Cdk Associates, L.l.c. within 3 months outperforms 6 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cdk Associates, L.l.c.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cdk Associates, L.l.c.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.52 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.63 LIMIT LIMIT LIMIT LIMIT LIMIT

Cdk Associates, L.l.c. Ownership Network

Ownership Network List of Cdk Associates, L.l.c.

No Data

Ownership Network Relation of Cdk Associates, L.l.c.

Insider Network Chart

Cdk Associates, L.l.c. Owned Company Details

What does Strongbridge Biopharma PLC do?

Who are the key executives at Strongbridge Biopharma PLC?

Cdk Associates, L.l.c. is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Caxton Corp , 10 percent owner Bruce Kovner , and director & Chief Executive Officer John Johnson .

Strongbridge Biopharma PLC (SBBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Strongbridge Biopharma PLC Insider Transactions

No Available Data

Cdk Associates, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Cdk Associates, L.l.c.. You might contact Cdk Associates, L.l.c. via mailing address: C/o Caxton Corporation, 731 Alexander Road, Building #2, Princeton Nj 08540.

Discussions on Cdk Associates, L.l.c.

No discussions yet.